- Home
- Editorial
- News
- Practice Guidelines
- Anesthesiology Guidelines
- Cancer Guidelines
- Cardiac Sciences Guidelines
- Critical Care Guidelines
- Dentistry Guidelines
- Dermatology Guidelines
- Diabetes and Endo Guidelines
- Diagnostics Guidelines
- ENT Guidelines
- Featured Practice Guidelines
- Gastroenterology Guidelines
- Geriatrics Guidelines
- Medicine Guidelines
- Nephrology Guidelines
- Neurosciences Guidelines
- Obs and Gynae Guidelines
- Ophthalmology Guidelines
- Orthopaedics Guidelines
- Paediatrics Guidelines
- Psychiatry Guidelines
- Pulmonology Guidelines
- Radiology Guidelines
- Surgery Guidelines
- Urology Guidelines
Urinary and male genital tract infections-Standard Treatment Guidelines
Infections of the urinary tract pose a serious health problem, also because of their frequent occurrence.
Clinical and experimental evidence support that the ascent of micro-organisms within the urethra is the most commom pathway leading to urinary tract infections, especially for organisms of enteric origin (I.e Escherichia coli and other Enterobacteriaeae). This is a logical explanation for the greater frequency of UTIs in women than in men and the increased risk of infection following bladder catherisation or instrumentation.
Ministry of Health and Family Welfare, Government of India has issued the Standard Treatment Guidelines for Urinary and male genital tract infections.
Following are the major recommendations :
Classification of Urinary and Male Genital Tract Infections
For practical clinical reasons, urinary tract infections (UTIs) and male genital tract infections are classified according to entities with predominating clinical symptoms: (I) uncomplicated lower UTI (cystitis); (2) uncomplicated pyelonephritis; (3) complicated UTI with or without pyelonephritis; (4) Urosepsis; (5) urethritis; and (6) prostatitis, epididymitis, orchitis.
Definitions
the definitions of bacteriuria and pyuria are as follows: Significant bacteriuria in adults:
- > 103 uropathogens/ml of midstream urine in acute uncomplicated cysitis in female;
- > 104 uropathogens/ml of midstream urine in acute uncomplicated pyelonephritis in female;
- > 104 uropathogens/ml of midstream urine of women or 104 uropathogens/ml of midstream urine in men (or in catheter, urine specimen in women) with complicated UTI.
In a suprapubic bladder puncture specimen any count of bacteria is relevant.
Asymptomatic bacteriuria (ABU)
ABU is defined as two positive urine cultures taken more that 24h apart with 105 uropathogens/ml of the same bacterial strain.
Pyuria
The requirement for pyuria is 10 white blood cells per high power field in the resuspended sediment of a centrifuged aliquot of urine or per mm3 in unspun urine. For the routine, a dipstick method can also be used, including leukocyte esterase test, or nitrite reaction.
Table 1. Classification of prostatitis according to NIDDK/NIH
I | Acute bacterial prostatitis (ABP) |
II | Chronic bacterial prostatitis (CBP) |
III | Chronic pelvic pain syndrome (CPPS) |
A Inflammatory CPPS: WBC in EPS/voided bladder urine-3 (VB3) or semen | |
B Noninflammatory CPPS: no WBC/EPS/VB3/semen | |
IV | Asymptomatic inflammatory prostatitis |
Diagnosis
Disease history, physical examination and urine analysis by dipstick including white and red blood cells as well as nitrate reaction is recommended for routine diagnosis.
In case of suspicion of pyelonephritis, evaluation of the upper urinary tract may be necessary to rule out upper urinary tract obstruction or stone disease.
Diagnosis | Most Frequent pathogens | Initial, empiric antimicrobial therapy | Therapy duration |
Cystitis, acute, Uncomplicated | E.coli Klebsiella Proteus Staphylococcus | Trimethoprim/ sulfamethoxazole Fluroquinolonea Alternatives: Fosfomycin Nitrofurantoin | 3 days 3 days 1 day 7 days |
Pyelonephritis, acute, uncomplicated | E.coli Proteus Klebsiella Other Enterobacteria Staphylococcus | Fluroquinolone Cephalosporin Gr. 2b/3a Alternatives Aminopenicillin / BLI Aminoglycoside | 7-10 days |
UTI with complicating | E.coli | Fluoroquinolone | 3-5 days after defervescence or control/ examination of complicating factor |
Factors Nosocomial UTI Pyelonephritis, acute, Complicated | Enterococcus Staphylococcus Klebsiella Proteus Enterobacter | Aminopenicillin / BLI Celphalosporin Gr. 2 Celphosporin Gr. 3 a Aminoglycosides In case of failure of initial therapy within 1-3 days or in clinically severe cases: | |
Other Enterobacteria Pseudomonas (Candida) | Anti-Pseudomonas active: Fluroquinolone, if not used initially Acylaminopenicillin/BLI Cephalosporin Gr. 3B Carbapenem + Aminoglycoside In case of Candida Fluconazole Amphotericin B | ||
Prostatitis, acute, chronic | E.coli | Fluroquinolonea | Acute : 2 weeks |
Epididymitis,acute | Other Enterobacteria | Alternative in acute bacterial prostatitis | |
Pseudomonas | Cephalosporin Gr. 2 | Chronic : 4-6 weeks or longer | |
Enterococcus | Cephalosporin Gr. 3a/b | ||
Staphylococcus | In case of Chlamydia or Ureaplasma: | ||
Chlamydia | Doxycyline | ||
Ureaplasma | Macrolide | ||
Urosepsis | E.coli | Cephalosporin Gr. 3a/b | 3-5 days after defervescence or control/ elimination of complicating factor |
Other Enterobacteria | Fluorquinolonea | ||
After urological interventions - | Anti-Pseudomonas active Acylaminopenicillin/BLI | ||
pathogens: Proteus Serratia | Carbapenem Aminoglycosides | ||
Enterobacter Pseudomonas |
a Fluroquinolone with mainly renal excretion; BLI= B- lactamase inhibitor. B 1 st,2nd and 3rd generation respectively (3a - without; 3b - with anti-Pseudomonas activity)
Treatment
Treatment of UTI is dependent on a variety of factors. An overview of most frequent pathogens, antimicrobial agents and duration of treatment in various conditions is given in table 2. Patients with recurrent UTI may be recommended prophylactic treatment. The following regimens have a documented effect in preventing recurrent UTI in women (table 3).
Agent | Dose |
Standard regimens (taken at bedtime) Trimethoprim / sulfamethoxazole Trimethoprim | 40/200mg/day or 3 times weekly 100mg/days |
Nitrofurantoin Others Cephalexin Norfloxacin | 50mg/day 125 or 250 mg/day 200 mg/day |
Ciprofloxacin | 125 mg/day |
Special situations:
- UTI in pregnancy. Asymptomatic bacteriuria is treated with a 7 day course based on sensitivity testing. For recurrent symptomatic infections, either cephalexin 125-250 mg/day or nitrofurantoin 50 mg/day may be used.
- UTI in postmenopausal women. In women with recurrent infection intravaginal estriol is recommended. If this does not work, in addition antibiotic prophylaxis is indicated.
- UTI in children. Treatment perioud should be extended to 7-10 days. Tetracyclines and fluroquinolones should not be used due to effects on teeth and cartilage.
- Acute uncomplicated UTI in young men. The treatment should last at least 7 days.
- UTI in diabetes mellitus and renal insufficiency. After treatment, a prophylactic regimen may be recommended afterwards.
- Complicated UTI due to urological disorders. The underlying disorded must be managed if permanent cure is to be expected. In order to avoid inducing resistant strains, treatment should be guided by urine culture whenever possible.
- Sepsis syndrome in Urology (urosepsis).
Patient with UTI may develop sepsis. Early signs of systemic inflammatory response (fever or hypothermia, tachycardia, tachypnea, hypotension,oliguria, leukopenia) should be recognized as the first signs of possible multiorgan failure. In conjunction with appropriate antibiotic therapy, life supporting therapy in collaboration with an intensive care specialist may be necessary. Any obstruction in the urinary tract needs to be drained.
Follow-up of patients with UTI
for follow-up after uncomplicated UTI and pyelonephritis in women, a urinanalysis by dipstick is enough for routine use.
In women who will have recurrence within 2 weeks, repeated urinary culture with antimicrobial testing and evaluation of the urinary tract is recommended.
In the elderly, newly developed recurrent UTI may warrant a full evaluation of the urinary tract.
In men with UTI, a urologic evaluation should be done when the patient is in adolescence, in cases with recurrent infection and in all causes with pyelonephritis. Also patients with prostatitis, epididymitis and orchitis should follow these recommendations.
In children, investigations are indicated after two episodes of UTI in girls and one episode in boys. Recommended investigations are ultrasonography of the urinary tract supplemented by voiding cystourethrography.
Urethritis
Symptomatic urethritis is characterized by dysuria and purulent discharge
Diagnosis
The Gram stain of secretion or urethral smear showing more than 5 leukocytes per high power field (HPF) (1,000) and eventually gonococci located intracellularly as Gram-negative diplococci indicate a pyogenic urethritis. A positive leukocyte esterase test or more than 10 leukocytes per high-power field (400) in the first voiding urine specimen are diagnostic.
Therapy
The following guidelines for therapy comply with the recommendations of the Centre for Disease Control and Prevention (1998).
For the treatment of gonorrhea the following antimicrobials can be recommended:
Cefixime 400 mg orally As a single dose Cefriaxone 250 mg i.m. As a single dose (i.m. with local anaesthetic) | Ciprofloxacin 500 mg orally as a single dose Ofloxacin 400 mg orally as single dose |
As gonorrhea is frequently accompanied by chalamydial infection, an antichlamydial active therapy should be added. The following treatment has been successfully applied in C. trachomatis infections :
First choice | Second choice |
Azithromycin 1 g (=4 caps.@250 mg) orally as single dose | Erythromycin 500 mg orally 4 times daily for 7 days |
Doxycycline 10 mg 2 times daily orally for 7 days | Ofloxacin 200 mg orally for 7 days |
if therapy fails, one should consider infections by T. vaginalis and / or Mycoplasma, which can be treated with a combination of metronidazole (2 g orally as single dose) and erythromycin (4 times daily 500 orally for 7 days).
Prostatitis, Epididymitis and Orchitis
Prostatitis
Treatment
- Acute bacterial prostatitis can be a serious infection and parenteral administration of high doses of bactericidal antibiotic such as aminoglycosides and a penicillin derivative or a 3rd generation cephalosporin are required until defervescence and normalization of infection parameters. In less severe cases a fluoroquinolone may be given orally for at least 10 days.
- In chronic bacterial prostatitis and chronic inflammatory pelvic pain syndrome, a fluoroquinolone or trimethorpim should be given orally for 2 weeks after the initial diagnosis. Then the patient should be reassessed and antibiotics only continued if pretreatment cultures were positive or if the patient reports positive effect of the treatment. A total treatment period of 4-6 weeks is recommended.
Epididymitis, Orchitis
The majority of cases of epididymitis are due to common urinary pathogens. Bladder outlet obstruction and urogenital malformations are risk factors for this type of infection.
Treatment
Prior to antimicrobial therapy a urethral swab and midstream urine should be obtained for microbiological investigation. Fluoroquinolones, preferably those which react well against C. trachomatis (e.g. ofloxacin, levofloxacin) should be first choice drugs because of their broad antibacterial spectra and their.
Table 4. Recommendations for perioperative antibacterial prophylaxis in urology
Procedure | Most common pathogens (s) | Antibiotic(s) of choice | Alternative antibiotic(s) | Remarks |
Open operations urinary tract including bowel segments | Enterobacteria Enterococci Anaerobes Wound infection: Staphylococci Enterbacteria Enterococci Wound infection: staphylococci Staphylococci Staphylococci | Aminopenicillin + BLI Cephalosporin 20 + Metronidazole | In high-risk patients: Cephalosporin3 Acylaminopenicillin + BLI | In all patients |
Urinary tract without bowel segments | Fluoroquinolone Cephalosporin 20 Aminopenicilin +BLI | in high-risk patients: Cephalosporin3 Acylaminopenicillin + BLI | in patients with increased risk of infection | |
Implant / prosthesis: penis, sphincter Reconstructive genital operation | Cephalosporin 10 /20 Cephalosporin 10 /20 | in all patients in secondary operations & in patients with increased risk of infection | ||
Other interventions outside of the | Cephalosporin 10 /20 | in patients with increased risk of infection | ||
urinary tract | ||||
Endoscopic – instrumental operations Urethra, prostate, bladder, ureter, kidney, incl. percutaneous litholapaxy and ESWL | Enterobacteria Staphylococci Enterococci | Fluoroquinolone Aminopenicillin + BLI Cephalosporin 20 Fosfomycin Trometamol | Cotrimozazole Aminoglycoside | In patients with increased risk of infection |
Diagnostic intervention Transrectal biopsy of the prostate (with thick needle) | Enterobacteria Enterococci Anaerobes Streptococci Enterobacteria Enterococci Staphylococci | Fluoroquinolonea Aminopenicllin + BLI Cephalosorin 20 + Metronidazole Fluoroquinolonea Aminopenicillin + BLI Cephalosporin 20 | Aminoglycoside Cotrimozazole | In all patients |
Perineal biopsy of the prostate, urethrocystosc opy, ureterorenosco py, percutaneous pyeloscopy, laparoscopic procedures | Cotrimoxazole | In patients with increased risk of infection |
BLI = B- Lactamase inhibitor, ESWL- extracorporeal shock-wave lithotripsy. 10 ,20 ,30 = 1st, 2nd, 3rd generation respectively.
11. Fluroquinolone with sufficient renal excretion
Favorable penetration into the tissues of the urogenital tract. In case C. trachomatis has been detected as etiologic agent, treatment could also be continued with doxycycline 200 mg/day for a total treatment period of at least 2 weeks. Macrolides may be alternative agents. In case of C .trachomatis infection, the sexual partner should be treated as well.
Antibiotics and α Blockers in combination
Urodynamic studies have shown increase urethral closing pressure in patients with chronic prostatitis. A combination treatment of α blockers and antibiotics is reported to have a higher cure rate than antibiotics alone in inflammatory CPPS. This is a treatment option favored by many urologists.
In general, surgery should be avoided in the treatment of prostatitis patients except for drainage of prostatic abscesses.
Perioperative Antibacterial Prophylaxis in Urological Surgery
The main aim of antimicrobial prophylaxis in urology is to prevent symptomatic / febrile genitourinary infections, such as acute pyelonephritis, prostatitis, edpididymitis and urosepsis as well as serious wound infections.
Antibiotic prophylaxis is recommended only for a maximum of 24 hours after surgery in most situations. More rampant use leads to antibiotic resistance and places an additional economic burden. Prophylaxis does not substitute for poor surgical asepsis.
Guidelines by The Ministry of Health and Family Welfare :
Prof. Rajesh Ahlawat
Chairman,
Department of Urology & Kidney Transplant,
Medanta Medicity
Reviewed By:
Dr Anup Kumar Gupta
Head of Department
Department of Urology
VMMC and Safdarjang Hospital,
New Delhi
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd